FBInvestor
Stocks / Crispr Therapeutics AG
Institutional Ownership

Crispr Therapeutics AG

CUSIP H17182108NAMEN AKTCRSPQ1 2026

No Form 4 insider transactions ingested yet

Insider (Form 4) filings for Crispr Therapeutics AG are fetched from SEC EDGAR on a rolling basis. Check back shortly.